Cvs Health (CVS) Share Value Declined While Proffitt & Goodson Trimmed Its Position by $482,760; Ares Cap (ARCC) Shareholder Joel Isaacson & Company Has Increased Stake by $480,505

CVS Health Corporation (NYSE:CVS) Logo

Proffitt & Goodson Inc decreased its stake in Cvs Health Corp (CVS) by 64.64% based on its latest 2019Q2 regulatory filing with the SEC. Proffitt & Goodson Inc sold 8,940 shares as the company’s stock declined 2.55% . The institutional investor held 4,890 shares of the medical and nursing services company at the end of 2019Q2, valued at $266,000, down from 13,830 at the end of the previous reported quarter. Proffitt & Goodson Inc who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $97.56 billion market cap company. The stock increased 0.37% or $0.28 during the last trading session, reaching $74.99. About 1.40 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 17.14% since December 4, 2018 and is downtrending. It has underperformed by 17.14% the S&P500. Some Historical CVS News: 02/05/2018 – CVS Health 1Q Rev $45.69B; 06/03/2018 – S&PGR: Could Lower CVS Ratings if There Are Delays in Reducing Leverage; 07/03/2018 – Aetna/CVS: Senate antitrust hearing on ice until AT&T trial decision – source familiar; 20/03/2018 – CVS Agreed to Buy Aetna Late Last Year; 30/04/2018 – Fidelity Select Medical Equipment Adds Teleflex, Exits CVS; 02/05/2018 – CVS SEES FY ADJ EPS $6.87 TO $7.08, SAW $1.88 TO $1.92; 06/03/2018 – CVS Health completes world’s third-largest corporate bond sale; 09/04/2018 – STAT Plus: Aetna auditor accuses CVS of improperly reporting generic prices to Medicare; 13/04/2018 – CVS Health Names Marc-David Munk, MD, MPH, MHCM, as Chief Medical Officer of MinuteClinic and Associate Chief Medical Officer o; 11/04/2018 – The plan will first be available to those using CVS’ pharmacy benefit manager Caremark

Joel Isaacson & Company Llc increased its stake in Ares Cap Corp (ARCC) by 245.72% based on its latest 2019Q2 regulatory filing with the SEC. Joel Isaacson & Company Llc bought 28,265 shares as the company’s stock rose 5.03% . The institutional investor held 39,768 shares of the company at the end of 2019Q2, valued at $713,000, up from 11,503 at the end of the previous reported quarter. Joel Isaacson & Company Llc who had been investing in Ares Cap Corp for a number of months, seems to be bullish on the $7.99B market cap company. The stock decreased 0.07% or $0.01 during the last trading session, reaching $18.7. About 623,912 shares traded. Ares Capital Corporation (NASDAQ:ARCC) has risen 10.92% since December 4, 2018 and is uptrending. It has outperformed by 10.92% the S&P500. Some Historical ARCC News: 14/05/2018 – Ares Management LLC Exits Position in Inspired Entertainment; 02/05/2018 – Ares Capital Corporation Declares Second Quarter 2018 Dividend of $0.38 Per Share and Announces March 31, 2018 Financial; 24/05/2018 – Ares Capital Presenting at Deutsche Bank Conference May 30; 02/04/2018 – Ares Cap Corp Intends to Recommend Proceeding With Financing Flexibility Provided for in New BDC Law; 30/03/2018 – Moody’s Assigns Provisional Ratings To Eight Classes Of Notes To Be Issued By Ares Xxxiir Clo Ltd; 21/03/2018 – Apollo to Ares Among Surprise Winners in Congress’ Spending Bill; 23/03/2018 – BDCs win leverage cap increase after US$1.3trn budget signed; 14/05/2018 – Principal Financial Group Inc. Exits Position in Ares Capital; 04/05/2018 – REG-Oaktree Oaktree Releases an Open Letter to Ranger Shareholders following Proposal from RDL Board to Appoint Ares as Investment Manager; 04/04/2018 – ARES CAPITAL IN AMENDED CREDIT FACILITY,BOOSTS BY $25M TO $2.1B

More notable recent Ares Capital Corporation (NASDAQ:ARCC) news were published by: Nasdaq.com which released: “Ares Capital (ARCC) Upgraded to Buy: What Does It Mean for the Stock? – Nasdaq” on October 31, 2019, also Fool.com with their article: “BDCs: 4 High-Dividend Ideas to Boost Your Portfolio – Motley Fool” published on November 19, 2019, Seekingalpha.com published: “Ares Capital: 8.5% Yield, Stable Income Potential – Seeking Alpha” on August 30, 2019. More interesting news about Ares Capital Corporation (NASDAQ:ARCC) were released by: Nasdaq.com and their article: “Ares Capital Corporation (ARCC) Ex-Dividend Date Scheduled for December 13, 2018 – Nasdaq” published on December 12, 2018 as well as Seekingalpha.com‘s news article titled: “Ares Capital Q2 net investment income rises 28% – Seeking Alpha” with publication date: July 30, 2019.

Investors sentiment decreased to 1.15 in Q2 2019. Its down 0.13, from 1.28 in 2019Q1. It fall, as 33 investors sold ARCC shares while 105 reduced holdings. 48 funds opened positions while 111 raised stakes. 136.40 million shares or 5.55% less from 144.42 million shares in 2019Q1 were reported. Palisade Capital Mgmt Ltd Llc Nj reported 0.15% in Ares Capital Corporation (NASDAQ:ARCC). Northwestern Mutual Wealth reported 2,030 shares. Selway Asset Mngmt holds 132,700 shares or 1.6% of its portfolio. Vaughan Nelson Invest Management LP reported 2.69M shares. Advisory Rech Incorporated holds 0.09% or 247,293 shares. Omers Administration has 0.65% invested in Ares Capital Corporation (NASDAQ:ARCC) for 3.45M shares. Parallax Volatility Advisers Lp holds 0% or 52 shares in its portfolio. Amer Natl Registered Advisor Inc owns 16,200 shares. Envestnet Asset Management Incorporated has invested 0% in Ares Capital Corporation (NASDAQ:ARCC). Goldman Sachs Gp owns 0% invested in Ares Capital Corporation (NASDAQ:ARCC) for 884,067 shares. Morgan Dempsey Capital Mgmt Limited Liability stated it has 372,305 shares or 2.51% of all its holdings. Peoples Services holds 682 shares. Segall Bryant & Hamill Llc holds 587,417 shares or 0.16% of its portfolio. 28,223 are owned by Pitcairn. Employees Retirement System Of Ohio stated it has 0.02% in Ares Capital Corporation (NASDAQ:ARCC).

Joel Isaacson & Company Llc, which manages about $2.52 billion and $687.05 million US Long portfolio, decreased its stake in Johnson & Johnson (NYSE:JNJ) by 7,198 shares to 47,167 shares, valued at $6.57M in 2019Q2, according to the filing. It also reduced its holding in Altria Group Inc (NYSE:MO) by 10,560 shares in the quarter, leaving it with 12,580 shares, and cut its stake in Merck & Co Inc (NYSE:MRK).

Since June 10, 2019, it had 5 insider purchases, and 0 insider sales for $502,120 activity. The insider BARTLETT STEVE bought 14,719 shares worth $270,115. On Thursday, August 1 the insider Kelly Daniel G Jr bought $110,640.

Proffitt & Goodson Inc, which manages about $273.50M and $404.16 million US Long portfolio, upped its stake in Vanguard Index Fds (VTI) by 3,259 shares to 198,938 shares, valued at $29.86 million in 2019Q2, according to the filing. It also increased its holding in Spdr Series Trust (SCPB) by 10,989 shares in the quarter, for a total of 90,425 shares, and has risen its stake in Vanguard Index Fds (VOO).

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Finance.Yahoo.com which released: “Centene and CVS Health Announce Agreement for CVS Health to Acquire IlliniCare Health – Yahoo Finance” on December 02, 2019, also Investorplace.com with their article: “Despite Black Friday Nostalgia, Glory Days Are Over for Best Buy Stock – Investorplace.com” published on December 03, 2019, Seekingalpha.com published: “CVS: Still A Buy – Seeking Alpha” on November 18, 2019. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Seekingalpha.com and their article: “CVS And The $70 Question – Seeking Alpha” published on November 11, 2019 as well as Fool.com‘s news article titled: “Why Dollar Tree Is Dragging – The Motley Fool” with publication date: November 29, 2019.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.